Table V.

Duration of Viral Shedding in Consecutive Stool Samples in Five Immunocompromised Hosts

Patient	Age/Sex	Underlying medical condition	Related treatment & complications	Virus	No. Samples	No. Weeks	Clinical Course
1	11 years, female	Beta thalassemia	URCB‐HSCT, GVHD	Norovirus GII	6	25	Diarrhea, cramping abdominal pain, emesis January – April 2007, new onset diarrhea, abdominal pain in July 2007
2	2 years, male	Severe infantile osteoporosis	URB‐HCST, GVHD	Norovirus GII	4	32	Symptomatic gastroenteritis October 2006 – May 2007 with failure to thrive
3	5 months, female	Severe combined immunodeficiency	Bone marrow transplants (2)	Norovirus GII	2	5	Hospitalized May 2008 – August 2009 with persistent diarrhea, intermittent adenovirus, rotavirus, and norovirus GII positive samples; 2 consecutive norovirus GII samples
4	6 years, male	Severe aplastic anemia	URCB‐HCST	Norovirus GII	2	18	Diarrhea, emesis March 2007; recurrent diarrhea in July 2007
5	20 months, male	Atypical rhabdoid tumor	Chemotherapy, multiple ASCTs	Astrovirus	4	12	Chemotherapy associated diarrhea and emesis, requiring multiple admissions, one episode associated with hypovolemic shock

URCB‐HSCT, unrelated cord blood hematopoietic stem cell transplant; GVHD, graft‐versus‐host disease; AGE: acute gastroenteritis; ASCT, autologous stem cell transplant.